Skip to main content
About the Institute
  • English
  • Français
  • Español
  • Russian
  • Portuguese

Breadcrumb

  1. Home
  2. Lung microbiota: a prognostic marker of COPD?
  • Our publications
    • News
    • Microbiota Mag
    • Thematic pages
    • Experts' point of view
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • About us
    • International Microbiota Observatory
    • Press room
    • Partnerships
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
  • Useful documents
    • How to talk about
    • Infographics
    • IBS Diagnosis Check List
    • Patients Stories

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

Lay public section

Find here your dedicated section
Gastroenterology
Gynecology
Pediatrics
General Medicine

Breadcrumb

  1. Home
  2. Lung microbiota: a prognostic marker of COPD?

Lung microbiota: a prognostic marker of COPD?

Lung condition
Pulmonology

Composition of the pulmonary microbiota could well become a marker of the severity of chronic obstructive pulmonary diseases. A team brought to light a correlation between the presence of some bacteria and prognosis at one year.

Gastroenterology
Gynecology
Pediatrics
General Medicine
  • Our publications
    • News
    • Microbiota Mag
    • Thematic pages
    • Experts' point of view
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • About us
    • International Microbiota Observatory
    • Press room
    • Partnerships
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
  • Useful documents
    • How to talk about
    • Infographics
    • IBS Diagnosis Check List
    • Patients Stories

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

Lay public section

Find here your dedicated section

Sources

This article is based on scientific information

Sharing is caring

Your colleagues might be interested in this topic. Why not share it?

  • Facebook
  • Twitter
  • LinkedIn
  • Mail

About this article

Created 08 January 2019
Updated 06 October 2021

 

Chronic obstructive pulmonary disease (COPD) affected 3.5 million people in France in 2010. It is responsible for over 100,000 hospitalizations per year for (sidenote: Data from the French Haute Autorité de Santé (HAS) ) . These episodes are associated with an increase of short- and medium-term mortality rates. Studies have shown that patients with COPD have a decreased lung microbiota diversity, and this dysbiosis has been cited as a potential cause of airway inflammation and decreased local immunity.

Diversity ensures a better prognosis

A new international study recently found a possible severity marker of COPD, that could identify patients at high risk of death. 102 patients hospitalized for AE were included in the study and their sputum was collected on Day 1. The microbiome was analyzed through 16S rRNA sequencing, but unfortunately it could not be compared to standard sputum cultures (cytobacteriological examination). Patients were then monitored to determine the survival rate one year after this hospitalization. According to different indices, there is an inverse linear correlation between microbiota diversity and one-year mortality: the more diverse the microbiota, the lower one-year mortality.

A dangerous bacterial combination

<>In this study, (sidenote: The technique used did not allow to identity relevant species from these two genera )  were discovered as having a strong prognostic potential. The first–Veillonella–is a bacterium from the oral commensal flora found in the lungs of adults. Its absence in the sputum of patients is associated to a 13-fold higher risk of death at one year, and Veillonella-positive (V+) patients have, in average, a shorter length of hospital stay than Veillonella-negative (V-) patients. Additionally, the presence of species from the Staphylococcus (S+) genus in the sputum is associated to a 7-fold higher risk of death at one year, and to longer hospital stays. A higher comorbidity in V‑/S+ patients was not detected: the combination of these two criteria is extremely unfavorable since V-/S+ patients are 85 times more likely to die within the first year than V+/S- patients. If these results are confirmed by other studies, screening for these two bacterial genera could thus become a “standard” test to identify high-risk patients.

 

Sources

Leitao Filho FS, Alotaibi NM, Ngan D et al. Sputum Microbiome is Associated With 1-Year Mortality Following COPD Hospitalizations. AJRCCM Articles in Press. 2019 May 15;199(10):1205-1213.

 

Tags
Dysbiosis COPD Lungs Staphylococcus Veillonella Microbiome Flora
    Created 08 January 2019
    Updated 06 October 2021

    About this article

    To know more about this topic.

    Main topic

    Lung condition

    Medical practice

    Pulmonology

    Content type

    News

    Continue reading

    News

    Infographics to share with your patients!

    Download original and engaging graphic materials to explain to your patients the essential role of th...

    Find out more
    17.04.2025

    Sensitivity to the additive E466: the role of the microbiota

    Read the article
    02.04.2025

    A type of vaginal dysbiosis for each type of infertility?

    Read the article
    Actu PRO : Alcoolisme : expliquer les troubles sociaux grâce au microbiote
    27.01.2021

    Alcoholism: explaining social disorders thanks to the microbiota

    Read the article

    Association between fungal dysbiosis and environment

    The fungal portion of the gut microbiota (or mycobiota) has been much less studied than the bacterial...

    Find out more
    L’axe intestin-cerveau dans le stress lié à la discrimination
    20.03.2023

    The gut-brain axis and discrimination-related stress

    Read the article
    Everything you need to know about Microbiota & Immunity
    15.09.2022

    Everything you need to know about Microbiota & Immunity

    Read the article

    How do you choose a probiotic for your patient?

    Faced with a plethora of products on the market, it's not always easy for health professionals to sug...

    Find out more
    • Our publications
      • News
      • Microbiota Mag
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
    • Useful documents
      • How to talk about
      • Infographics
      • IBS Diagnosis Check List
      • Patients Stories

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube
      • Instagram
      • Bluesky

    Lay public section

    Find here your dedicated section
    Gastroenterology
    Gynecology
    Pediatrics
    General Medicine
    • English
    • Français
    • Español
    • Russian
    • Portuguese

    Browse the site

    • Our publications
      • News
      • Microbiota Mag
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
    • Useful documents
      • How to talk about
      • Infographics
      • IBS Diagnosis Check List
      • Patients Stories

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube
      • Instagram
      • Bluesky

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    General Medicine

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

    Lay public section

    Find here your dedicated section

    Redirection

    You are about to be redirected and leave our website

    • Be redirected
    • Stay on the Biocodex Microbiota Institute's website

    Stay with us !

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    Explore

    14.05.2025

    Towards worldwide redefinition of healthy vaginal microbiota

    Read the article
    07.05.2025

    The microbial-metabolic nexus in colon cancer

    Read the article
    02.05.2025

    A new lens on chlamydia: beyond behavior, into the microbiome

    Read the article

    Stay updated

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    • Our publications
      • News
      • Microbiota Mag
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
    • Useful documents
      • How to talk about
      • Infographics
      • IBS Diagnosis Check List
      • Patients Stories

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube
      • Instagram
      • Bluesky

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    General Medicine

    Lay public section

    Find here your dedicated section

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

    © 2025 Biocodex. All rights reserved.

    • Legal notice
    • GTU
    • Data protection policy
    • Sitemap
    • Cookies settings
    • Digital accessibility : partially compliant
    Biocodex logo